Je Hwan Won

ORCID: 0000-0002-5901-295X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vascular Procedures and Complications
  • Central Venous Catheters and Hemodialysis
  • Peripheral Artery Disease Management
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Vascular Malformations and Hemangiomas
  • Lymphatic Disorders and Treatments
  • Liver Disease and Transplantation
  • Organ Transplantation Techniques and Outcomes
  • Diagnosis and Treatment of Venous Diseases
  • Vascular anomalies and interventions
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders
  • Renal and Vascular Pathologies
  • Liver Disease Diagnosis and Treatment
  • Lymphatic System and Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Esophageal and GI Pathology
  • Aortic aneurysm repair treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Vasculitis and related conditions
  • Tracheal and airway disorders
  • Pancreatic and Hepatic Oncology Research
  • Uterine Myomas and Treatments
  • Eosinophilic Esophagitis
  • Medical Imaging and Pathology Studies

Ajou University
2015-2025

Ajou University Hospital
2014-2025

Yonsei University
1996-2025

University of Suwon
2016

Suwon Research Institute
2015

Severance Hospital
2012-2013

Ewha Womans University
1999-2008

Hospital of the University of Pennsylvania
2005

Korea Institute of Radiological and Medical Sciences
1999

Iwate University
1996

The IN.PACT Global Study is the largest prospective, multicenter, independently adjudicated trial to evaluate a paclitaxel drug-coated balloon in patients with lifestyle-limiting claudication and/or ischemic rest pain due atherosclerotic disease of femoropopliteal artery and includes complex lesions beyond what are typically included randomized controlled trials. Randomized trials have demonstrated safety efficacy balloons for treatment Trans-Atlantic Inter-Society Consensus Document II A B...

10.1016/j.jcin.2018.02.019 article EN cc-by-nc-nd КАРДИОЛОГИЯ УЗБЕКИСТАНА 2018-05-01

To report the 36-month outcomes from prospective, multicenter, single-arm IN.PACT Global Study (

10.1177/1526602820931477 article EN cc-by-nc Journal of Endovascular Therapy 2020-06-25

We evaluated 158 legs from 79 consecutive patients who had undergone both ankle-brachial index (ABI) measurements and angiography for claudication symptoms between January 2007 December 2008. The diagnosis of peripheral arterial disease (PAD) in the individual was established by angiography. Ankle-brachial considered abnormal if it <0.9. sensitivity specificity ABI 61% 87%, respectively. To assess factors affecting validity PAD, multivariate logistic regression analysis conducted. odds...

10.1177/0003319709348295 article EN Angiology 2009-09-16

Biliary complication (BC) is still regarded as the Achilles’ heel of a living donor liver transplantation (LDLT). This study aims to evaluate longterm outcomes duct‐to‐duct (DD) biliary reconstruction using 7‐0 suture and identify risk factors BCs after LDLTs. Data 140 LDLTs between 2006 2015 were analyzed. All reconstructions performed DD anastomoses suture: 102 for right lobe, 20 left 18 posterior sector grafts. BC was defined bile leakage (BL) or stricture (BS), median follow‐up time LDLT...

10.1002/lt.25074 article EN Liver Transplantation 2018-04-10

To assess lymphangiography findings and outcome of lymphatic embolisation to manage chyle leak after neck surgery.

10.1259/bjr.20220831 article EN British Journal of Radiology 2023-07-02

10.1097/01.rvi.0000127899.31047.0e article EN Journal of Vascular and Interventional Radiology 2004-06-01

Abstract Background and Aim Circulating microRNA (miR)‐122 has recently been investigated as a potential biomarker of various hepatic diseases, such chronic hepatitis hepatocellular carcinoma (HCC). We the association between plasma miR‐122 levels treatment outcomes following transarterial chemoembolization (TACE) in HCC patients. Methods included 177 patients treated with TACE study; refractoriness liver transplantation‐free survival were evaluated during follow up. Pretreatment assessed...

10.1111/jgh.13448 article EN Journal of Gastroenterology and Hepatology 2016-05-19

Lee JH, Won Oh C-K. Impact of the ratio graft kidney volume to recipient body surface area on function after live donor transplantation. Clin Transplant 2011: 25: E647–E655. © 2011 John Wiley & Sons A/S. Abstract: Functioning nephron mass is a determinant transplant recipients. The and its weight have been reported be surrogates mass. To investigate impact ratios (BSA) within six months post-transplantation, we measured volume, using computed tomography with 3-dimensional reconstruction...

10.1111/j.1399-0012.2011.01502.x article EN Clinical Transplantation 2011-09-09

Dieulafoy's lesion is an uncommon cause of gastrointestinal bleeding. Hemorrhage occurs through mucosal erosion from abnormally dilated submucosal artery. Although usually located in the stomach, it may occur anywhere tract. We report here on a case jejunal presenting as mass and short segment stricture CT enteroclysis.

10.3349/ymj.2005.46.3.445 article EN cc-by-nc Yonsei Medical Journal 2005-01-01

The rendezvous approach is a salvage technique after failure of endoscopic retrograde cholangiography (ERC). In certain circumstances, percutaneous-endoscopic (PE-RV) preferred, and ultrasound-guided (EUS-RV) difficult to perform. We aimed evaluate PE-RV outcomes, describe the techniques, identify potential indications for over EUS-RV.Retrospective analysis was conducted prospectively designed ERC database between January 2005 December 2016 at tertiary referral center including cases where...

10.1097/md.0000000000008991 article EN cc-by-nc Medicine 2017-11-28

Background:We investigated an association between the levels of plasma microRNA (miRNA)-21, -26a, and -29a-3p treatment outcomes following transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).Methods: A total 198 TACE-treated HCC were followed up for TACE refractoriness liver transplantation (LT)-free survival.Pretreatment miRNA-21, measured using quantitative real-time polymerase chain reaction.Results: During mean follow-up 22.3 (range, 0.7-79) months, 118...

10.3346/jkms.2018.33.e6 article EN cc-by-nc Journal of Korean Medical Science 2017-12-01
Coming Soon ...